Showerblog.site

UPDATE 4-14-14:  A "friend" of Adams posts this expose on another fraud in supplements Adams is selling.
Can You Trust Your Supplements: http://jonbarron.org/dietary-supplements/can-you-trust-your-supplements

As it stands now, based on some recently uncovered information, the "health ranger" is now a "News Journalist".

Software creator to "editor" and also a so-called independent reviewer.

You have to be the real judge of exactly what color chameleon it is today.  Might have been different yesterday, perhaps different tomorrow.

As I've mentioned I have been copied from the inception of this wunderkind's creations.  He started lurking in 2003 and copying without attribution.  Could be flattery, maybe.  But what about his defamation, and I've never even talked with the fellow.

I've always stood on the fact that I have worked in media with many well respected companies over the years, and I follow ethical practices.

Here's one thing you might find interesting. If there was real transparency that would be better. After all, isn't it "Truth Publishing"?

Sound too good to be true? That's what I thought at first, too. But then I took the time to meet the people, research the rainforest herbs and experience their healing effects myself. Now I'm not only convinced this is the company that's going to pave the way to sustainable business practices in the coming years, I'm also convinced it represents the very best business opportunity available in the natural health industry today for anyone interested in an independent, at-home business where you control your own financial destiny. That's no casual claim, either. Keep reading to see why I've become such an outspoken advocate of the Amazon Herb Company, even while refusing to become a associate myself (due to journalism ethics, because if I got involved with the company, I could no longer offer a truly independent opinion like what you're reading here).

This person is connected with the Wyoming software company linked with Adams

DONA C COPELAND SECRETARY 1501 STAMPEDE AVENUE, #9005 CODY,WY 82414 Date of Taking Office: 03/12/2009 Last Updated: 03/06/2014

http://www.naturalnews.com/Report_Amazon_Herb_Company_0.html

Corporation documents filed in Arizona over quite a few years show otherwise -


http://starpas.azcc.gov/scripts/cgiip.exe/WService=wsbroker1/names-detail.p?name-id=05225664&type=CORPORATION

	Arizona Corporation Commission
04/11/2014	State of Arizona Public Access System	11:58 AM

Jump To...

Annual Reports

Scanned Documents

Amendments

Microfilm

Corporate Inquiry
File Number:  -0522566-4
Corp. Name: CONSUMER WELLNESS CENTER

Domestic Address

6336 N. ORACLE ROAD, #326-315

TUCSON,  AZ  85704

Statutory Agent Information

Agent Name:  MICHAEL ADAMS

Agent Mailing Address:

6336 N. ORACLE ROAD,

#326-315

TUCSON,  AZ  85704

Agent Physical Address:

180 W. MAGEE ROAD

STE. 116

ORO VALLEY,  AZ  85704

Agent Status: APPOINTED 01/31/2007

Agent Last Updated: 09/16/2008

Additional Corporate Information

Corporation Type: NON-PROFIT	Business Type: EDUCATIONAL
Incorporation Date:  01/22/1990	Corporate Life Period: PERPETUAL
Domicile:  ARIZONA	County: PIMA
Approval Date:  01/25/1990	Original Publish Date:  06/07/1990

Officer Information

MICHAEL ADAMS PRESIDENT 6336 N. ORACLE ROAD, #326-315 TUCSON,AZ 85704 Date of Taking Office: 12/07/2006 Last Updated: 03/06/2014	DONA C COPELAND SECRETARY 1501 STAMPEDE AVENUE, #9005 CODY,WY 82414 Date of Taking Office: 03/12/2009 Last Updated: 03/06/2014
SHEH ADAMS TREASURER 6336 N. ORACLE ROAD, #326-315 TUCSON,AZ 85704 Date of Taking Office: 02/27/2007 Last Updated: 03/06/2014

Director Information

SHEH ADAMS DIRECTOR 6336 N. ORACLE ROAD, #326-315 TUCSON,AZ 85704 Date of Taking Office: 02/27/2007 Last Updated: 03/06/2014

MICHAEL ADAMS DIRECTOR 6336 N. ORACLE ROAD, #326-315 TUCSON,AZ 85704 Date of Taking Office: 12/07/2006 Last Updated: 03/06/2014

Annual Reports

Next Annual Report Due: 02/22/2015

File Year	File Month	Date Received	Reason Returned	Date Returned	Extension
2014	02	02/18/2014
2013	02	02/19/2013
2012	02	02/19/2013
2011	02	02/15/2011
2010	02	02/01/2010
2009	02	04/06/2009
2008	02	05/30/2008
2007	02	04/23/2007			08/22/2008
2006	02	10/18/2006
2005	02	06/02/2005
2004	02	09/13/2004
2003	02	02/24/2003
2002	02	03/21/2002
2001	02	05/15/2001
2000	02	03/30/2000
1999	02	02/23/1999
1998	02	04/23/1998
1996	10	01/30/1997
1995	10	05/03/1996
1994	10	02/17/1995	REPLACEMENT CHECK	04/29/1996	04/15/1996
1993	10	03/15/1994			04/15/1995
1992	10	02/17/1993
1991	10	02/14/1992
1990	10	02/14/1991

Back To Top

Look at these *** in particular 

Scanned Documents

(Click on gray button - if present - to view document - will open in a new window.)

(If gray button is not present, please check back later.)

Document Number	Description	Date Received
	96 ANNUAL REPORT ***	01/30/1997
	98 ANNUAL REPORT	04/23/1998
	99 ANNUAL REPORT	02/23/1999
	00 ANNUAL REPORT	03/30/2000
	01 ANNUAL REPORT	05/15/2001
	02 ANNUAL REPORT	03/21/2002
	03 ANNUAL REPORT	02/24/2003
	04 ANNUAL REPORT	09/13/2004
	05 ANNUAL REPORT	06/02/2005
	06 ANNUAL REPORT	10/18/2006
	PUB OF AMENDMENT ***	02/22/2007
	07 ANNUAL REPORT	04/23/2007
	08 ANNUAL REPORT	05/30/2008
	CHANGE(S)	09/11/2008
	09 ANNUAL REPORT	04/06/2009
	10 ANNUAL REPORT	02/01/2010
	11 ANNUAL REPORT	02/15/2011
	12 ANNUAL REPORT	02/17/2012
	13 ANNUAL REPORT	02/19/2013
	14 ANNUAL REPORT	02/18/2014

Back To Top

Amendments

Amendment Date	Amendment Type	Publish Date	Publish Exception
01/31/2007	NAME CHANGE	02/22/2007
09/18/1990	AMENDMENT	10/16/1990

Back To Top

Name Changes / Mergers

Description	Corporation Name	Date
CHANGED FROM	TERRA CHRISTA COMMUNICATIONS, INC.	01/31/2007

Microfilm

Location	Date Received	Description
10508009029	01/22/1990	ARTICLES
20100055018	06/07/1990	PUBLICATION OF ARTICLES
10569008035	09/18/1990	AMENDMENT
20105061010	10/16/1990	PUBLICATION OF AMENDMENT
10594002032	02/14/1991	90 ANNUAL REPORT
10663021008	02/14/1992	91 ANNUAL REPORT
10737012031	02/17/1993	92 ANNUAL REPORT
10833023030	03/15/1994	93 ANNUAL REPORT
20168030038	02/16/1995	94 EXTENSION
10922023035	02/17/1995	94 ANNUAL REPORT
20189012008	02/16/1996	95 EXTENSION
20192086011	04/25/1996	DELINQUENT NOTICE/MAIL RETURNED
11041021006	05/03/1996	95 ANNUAL REPORT
20198001002	09/04/1996	AGENT APPOINTMENT/CORP ADDR CHG
11107010032	01/30/1997	96 ANNUAL REPORT
11221018035	03/20/1998	98 ANNUAL REPORT
31524002008	02/23/1999	99 ANNUAL REPORT
20247036011	07/02/1999	CORP ADDRESS CHG
31573000265	03/30/2000	00 ANNUAL REPORT
31619000139	05/15/2001	01 ANNUAL REPORT
31657000213	03/21/2002	02 ANNUAL REPORT
31708001268	02/24/2003	03 ANNUAL REPORT
31791001024	07/13/2004	NOTICE OF PENDING ADMINISTRATIVE DISSOLUTION
31826000643	09/13/2004	04 ANNUAL REPORT
31886000518	06/02/2005	05 ANNUAL REPORT
32011002634	10/18/2006	06 ANNUAL REPORT
11776001040	01/31/2007	AMENDMENT
32029004018	02/22/2007	PUB OF AMENDMENT
32052001966	04/23/2007	07 ANNUAL REPORT
11802009013	02/15/2008	EXTENSION
32158000428	05/30/2008	08 ANNUAL REPORT
32162003293	09/11/2008	CHANGE(S)

---

Despite the occasional negative publicity surrounding vitamin E, this nutrient has proven itself time and again to be one amazing antioxidant. Case in point: Research published earlier this year in the Journal of the American Medical Association has shown that vitamin E can help slow functional decline associated with Alzheimer’s disease.¹

This development is particularly significant since no cure for Alzheimer’s exists—only treatments to slow the progression of the disease. Currently, two main classes of drugs are approved for Alzheimer’s treatment: cholinesterase inhibitors (such as Aricept®, Exelon® and Razadyne®) and memantine (Namenda®).

These drugs may treat the symptoms of Alzheimer’s—like memory loss and problems with reasoning—but they also have their fair share of troublesome side effects, including nausea, vomiting, loss of appetite, increased bowel movements, headache and dizziness.

Researchers have found, however, that vitamin E may actually work better than certain conventional treatments in slowing cognitive decline.

In this randomized, double-blind, placebo-controlled study, investigators wanted to determine the effectiveness of vitamin E, mematine or a combination of the two in slowing the progression of mild to moderate Alzheimer’s disease in patients already taking a cholinesterase inhibitor like Aricept®.

Participants received 2,000 IU vitamin E (alpha tocopherol) per day, 20 mg memantine per day, a combination of the two or a placebo.

At the end of the five-year study period, the researchers analyzed data from 561 of the participants (140 taking vitamin E, 142 taking memantine, 139 using the combination treatment and 140 on placebo). They found that the group given the vitamin E had a delay in clinical progression of the disease of 19 percent per year (in other words, a delay of 6.2 months) compared to the placebo group.

In addition, those in the vitamin E group did not demand increased attention from caregivers.

More importantly, contrary to other studies that have implicated vitamin E as the cause of increased mortality—especially at higher doses^2-3—this study actually concluded that vitamin E has a good safety profile, with greater death frequency in the groups that took the memantine or the vitamin E/memantine combination than the vitamin E group.

In conclusion, the researchers wrote that, among patients with mild to moderate Alzheimer’s, “2,000 IU/day of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate Alzheimers disease by slowing functional decline and decreasing caregiver burden.”

This isn’t the first study to praise vitamin E’s brain-protective powers. Another study showed that people with the highest plasma levels of total vitamin E, total tocopherols and total tocotrienols had a reduced risk of developing Alzheimer’s disease compared to those with the lowest levels.⁴
 
Specifically, people with the highest plasma total vitamin E or total tocopherols had a 45 percent decreased risk of developing the disease, and those with the highest total tocotrienols had a 54 percent reduction in risk, as compared to people with the lowest levels.

Is E an Option for You?

Only a qualified medical professional—ideally one with vast knowledge in nutritional supplementation—can determine whether or not high doses of vitamin E would be appropriate for you or your loved one with Alzheimer’s.

The recommended daily allowance for healthy adults is a meager 22.4 IU, but tolerable upper intake levels go as high as 1,500 IU.⁵ The JAMA study used 2,000 IU. For general brain and memory health/maintenance, 400 IU per day should suffice.

In many cases, the risks of disease progression far outweigh any potential risks of taking high doses of certain drugs or supplements—but only you and your doctor can make that determination. But, as this study shows, vitamin E offers great promise, and its potential should not be ignored.

References:

1. Dysken MW, et al. JAMA. 2014 Jan 1;311(1):33-44.
2. Miller ER 3rd, et al. Ann Intern Med. 2005 Jan 4;142(1):37-46.
3. Boothby LA and Doering PL. Ann Pharmacother. 2005 Dec;39(12):2073-80.
4. Mangialasche F, et al. J Alzheimers Dis. 2010;20(4):1029-37.
5. Institute of Medicine. http://iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/New%20Material/4_%20UL%20Values_Vitamins%20and%20Elements.pdf.

SOURCE: Larissa Long


Selections from Natural Health News